"Periocular molluscum contagiosum in an atopic dermatitis patient treated with upadacitinib." Journal of Dermatological Treatment, 33(7), pp. 3068–3069
Acknowledgements
For this work AbbVie provided the study drug Upadacitinib (Rinvoq) through a Compassionate Use Program activated according to the DM September 7 2017.
Disclosure statement
No potential conflict of interest was reported by the author(s).